Short answer · Medically reviewed summary · Last updated: 2026-04-08
TL;DR: The exact cause of Melkersson-Rosenthal Syndrome (MRS) remains unknown, though it is widely considered a multifactorial condition involving a combination of genetic predisposition and immune-mediated inflammation. Current research points toward a complex interplay between chronic granulomatous inflammation, potential autoimmune triggers, and localized vascular abnormalities that lead to the syndrome's characteristic triad of symptoms. What is known about the causes of Melkersson-Rosenthal Syndrome? While medical science has yet to pinpoint a single "root cause" for Melkersson-Rosenthal Syndrome, researchers generally classify it as a rare neuro-mucocutaneous disorder.
1 people with Melkersson-Rosenthal Syndrome have shared their first-person experience on this question at DiseaseMaps.
TL;DR: The exact cause of Melkersson-Rosenthal Syndrome (MRS) remains unknown, though it is widely considered a multifactorial condition involving a combination of genetic predisposition and immune-mediated inflammation. Current research points toward a complex interplay between chronic granulomatous inflammation, potential autoimmune triggers, and localized vascular abnormalities that lead to the syndrome's characteristic triad of symptoms.
While medical science has yet to pinpoint a single "root cause" for Melkersson-Rosenthal Syndrome, researchers generally classify it as a rare neuro-mucocutaneous disorder. The prevailing theory is that the condition arises from an abnormal immune response, which triggers the formation of granulomas—small areas of inflammation—within the tissues of the face and lips. In our community of 73 members on DiseaseMaps.org, many report that these inflammatory episodes appear to be linked to systemic immune system fluctuations, suggesting that Melkersson-Rosenthal Syndrome acts as an inflammatory reaction to unidentified internal or external stimuli.
There is evidence to suggest that Melkersson-Rosenthal Syndrome may have a hereditary component, although it does not follow a simple Mendelian inheritance pattern. Some clinical literature points to a potential autosomal dominant inheritance with incomplete penetrance, meaning that while a genetic predisposition can be passed down, not everyone who inherits the susceptibility will go on to develop the full syndrome. Researchers are currently investigating specific gene loci on chromosome 9p11, which have been linked to cases of Melkersson-Rosenthal Syndrome in some families, though this is not present in every patient.
Because the cause is not fully understood, clinicians often distinguish between "causes" (the underlying mechanism) and "triggers" (factors that provoke a flare-up). Patients with Melkersson-Rosenthal Syndrome often note that symptoms worsen following certain exposures. Common suspected triggers include:
Current research into Melkersson-Rosenthal Syndrome is focused on identifying the immunological pathways that lead to granuloma formation. Scientists are utilizing biopsy analysis to look for cytokine signatures—the chemical messengers of the immune system—that might explain why the inflammation remains localized to the face and lips. By studying these pathways, researchers hope to move beyond symptomatic treatment toward therapies that can modulate the immune system to prevent the characteristic swelling and nerve palsy associated with the condition.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.